TNM-based risk eligibility for adjuvant trials in renal cell carcinoma

被引：7

作者：

Bedke, Jens ^{[1
,2
]}

Bex, Axel ^{[3
,4
,5
]}

机构：

[1] Klinikum Stuttgart Katharinenhosp, Dept Urol & Transplantat Surg, D-70174 Stuttgart, Germany

[2] Stuttgart Canc Ctr Tumorzentrum Eva Mayr Stihl, Stuttgart, Germany

[3] Royal Free London NHS Fdn Trust, London, England

[4] UCL, UCL Div Surg & Intervent Sci, London, England

[5] Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, Dept Urol, Amsterdam, Netherlands

来源：

LANCET | 2023年 / 402卷 / 10407期

关键词：

DOUBLE-BLIND; EVEROLIMUS; SUNITINIB;

D O I：

10.1016/S0140-6736(23)01128-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1018 / 1019

页数：2

共 12 条

[1] The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma [J].

Bedke, Jens ;

Albiges, Laurence ;

Capitanio, Umberto ;

Giles, Rachel H. ;

Hora, Milan ;

Ljungberg, Borje ;

Marconi, Lorenzo ;

Klatte, Tobias ;

Volpe, Alessandro ;

Abu-Ghanem, Yasmin ;

Dabestani, Saeed ;

Fernandez-Pello, Sergio ;

Hofmann, Fabian ;

Kuusk, Teele ;

Tahbaz, Rana ;

Powles, Thomas ;

Bex, Axel .

EUROPEAN UROLOGY, 2023, 83 (01) :10-+

[2] A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy [J].

Buettner, Florian A. ;

Winter, Stefan ;

Stuehler, Viktoria ;

Rausch, Steffen ;

Hennenlotter, Joerg ;

Fuessel, Susanne ;

Zastrow, Stefan ;

Meinhardt, Matthias ;

Toma, Marieta ;

Jeronimo, Carmen ;

Henrique, Rui ;

Miranda-Goncalves, Vera ;

Kroeger, Nils ;

Ribback, Silvia ;

Hartmann, Arndt ;

Agaimy, Abbas ;

Stoehr, Christine ;

Polifka, Iris ;

Fend, Falko ;

Scharpf, Marcus ;

Comperat, Eva ;

Wasinger, Gabriel ;

Moch, Holger ;

Stenzl, Arnulf ;

Gerlinger, Marco ;

Bedke, Jens ;

Schwab, Matthias ;

Schaeffeler, Elke .

GENOME MEDICINE, 2022, 14 (01)

[3] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma [J].

Choueiri, T. K. ;

Tomczak, P. ;

Park, S. H. ;

Venugopal, B. ;

Ferguson, T. ;

Chang, Y. -H. ;

Hajek, J. ;

Symeonides, S. N. ;

Lee, J. L. ;

Sarwar, N. ;

Thiery-Vuillemin, A. ;

Gross-Goupil, M. ;

Mahave, M. ;

Haas, N. B. ;

Sawrycki, P. ;

Gurney, H. ;

Chevreau, C. ;

Melichar, B. ;

Kopyltsov, E. ;

Alva, A. ;

Burke, J. M. ;

Doshi, G. ;

Topart, D. ;

Oudard, S. ;

Hammers, H. ;

Kitamura, H. ;

Bedke, J. ;

Perini, R. F. ;

Zhang, P. ;

Imai, K. ;

Willemann-Rogerio, J. ;

Quinn, D. I. ;

Powles, T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08) :683-694

[4] Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial [J].

Choueiri, Toni K. ;

Escudier, Bernard ;

Powles, Thomas ;

Tannir, Nizar M. ;

Mainwaring, Paul N. ;

Rini, Brian I. ;

Hammers, Hans J. ;

Donskov, Frede ;

Roth, Bruce J. ;

Peltola, Katriina ;

Lee, Jae Lyun ;

Heng, Daniel Y. C. ;

Schmidinger, Manuela ;

Agarwal, Neeraj ;

Sternberg, Cora N. ;

McDermott, David F. ;

Aftab, Dana T. ;

Hessel, Colin ;

Old, Christian Scheff ;

Schwab, Gisela ;

Hutson, Thomas E. ;

Pal, Sumanta ;

Motzer, Robert J. .

LANCET ONCOLOGY, 2016, 17 (07) :917-927

[5] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].

Gerlinger, Marco ;

Rowan, Andrew J. ;

Horswell, Stuart ;

Larkin, James ;

Endesfelder, David ;

Gronroos, Eva ;

Martinez, Pierre ;

Matthews, Nicholas ;

Stewart, Aengus ;

Tarpey, Patrick ;

Varela, Ignacio ;

Phillimore, Benjamin ;

Begum, Sharmin ;

McDonald, Neil Q. ;

Butler, Adam ;

Jones, David ;

Raine, Keiran ;

Latimer, Calli ;

Santos, Claudio R. ;

Nohadani, Mahrokh ;

Eklund, Aron C. ;

Spencer-Dene, Bradley ;

Clark, Graham ;

Pickering, Lisa ;

Stamp, Gordon ;

Gore, Martin ;

Szallasi, Zoltan ;

Downward, Julian ;

Futreal, P. Andrew ;

Swanton, Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892

[6] Adjuvant Treatment for High-Risk Clear Cell Renal Cancer Updated Results of a High-Risk Subset of the ASSURE Randomized Trial [J].

Haas, Naomi B. ;

Manola, Judith ;

Dutcher, Janice P. ;

Flaherty, Keith T. ;

Uzzo, Robert G. ;

Atkins, Michael B. ;

DiPaola, Robert S. ;

Choueiri, Toni K. .

JAMA ONCOLOGY, 2017, 3 (09) :1249-1252

[7] Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial [J].

Haas, Naomi B. ;

Manola, Judith ;

Uzzo, Robert G. ;

Flaherty, Keith T. ;

Wood, Christopher G. ;

Kane, Christopher ;

Jewett, Michael ;

Dutcher, Janice P. ;

Atkins, Michael B. ;

Pins, Michael ;

Wilding, George ;

Cella, David ;

Wagner, Lynne ;

Matin, Surena ;

Kuzel, Timothy M. ;

Sexton, Wade J. ;

Wong, Yu-Ning ;

Choueiri, Toni K. ;

Pili, Roberto ;

Puzanov, Igor ;

Kohli, Manish ;

Stadler, Walter ;

Carducci, Michael ;

Coomes, Robert ;

DiPaola, Robert S. .

LANCET, 2016, 387 (10032) :2008-2016

[8] Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma [J].

Motzer, R. J. ;

Escudier, B. ;

McDermott, D. F. ;

George, S. ;

Hammers, H. J. ;

Srinivas, S. ;

Tykodi, S. S. ;

Sosman, J. A. ;

Procopio, G. ;

Plimack, E. R. ;

Castellano, D. ;

Choueiri, T. K. ;

Gurney, H. ;

Donskov, F. ;

Bono, P. ;

Wagstaff, J. ;

Gauler, T. C. ;

Ueda, T. ;

Tomita, Y. ;

Schutz, F. A. ;

Kollmannsberger, C. ;

Larkin, J. ;

Ravaud, A. ;

Simon, J. S. ;

Xu, L-A ;

Waxman, I. M. ;

Sharma, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) :1803-1813

[9] Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial [J].

Motzer, Robert J. ;

Escudier, Bernard ;

Oudard, Stephane ;

Hutson, Thomas E. ;

Porta, Camillo ;

Bracarda, Sergio ;

Gruenwald, Viktor ;

Thompson, John A. ;

Figlin, Robert A. ;

Hollaender, Norbert ;

Urbanowitz, Gladys ;

Berg, William J. ;

Kay, Andrea ;

Lebwohl, David ;

Ravaud, Alain .

LANCET, 2008, 372 (9637) :449-456

[10] External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer [J].

Oza, Bhavna ;

Eisen, Tim ;

Frangou, Eleni ;

Stewart, Grant D. ;

Bex, Axel ;

Ritchie, Alastair W. S. ;

Kaplan, Rick ;

Smith, Benjamin ;

Davis, Ian D. ;

Stockler, Martin R. ;

Albiges, Laurence ;

Escudier, Bernard ;

Larkin, James ;

Joniau, Steven ;

Hancock, Barry ;

Hermann, Gregers G. ;

Bellmunt, Joaquim ;

Parmar, Mahesh K. B. ;

Royston, Patrick ;

Meade, Angela .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) :1772-+

← 1 2 →